Trial Profile
Botulinum toxinA injection for the treatment of neurogenic detrusor overactivity secondary to spinal cord injury: multi-institutional experience in Japan.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Feb 2016
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Overactive bladder
- Focus Adverse reactions; Therapeutic Use
- 02 Feb 2016 New trial record